Swain Judith L
Insider CIK 1413573 · LXRX Director · RXDX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2026-06-03 | 2026-06-04 | 89,312 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2026-06-03 | 2026-06-04 | 89,312 | — | $0 | 174,486 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2026-05-01 | 2026-05-04 | 43,478 | — | $0 | 43,478 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2026-05-01 | 2026-05-04 | 35,714 | — | $0 | 35,714 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2025-06-03 | 2025-06-03 | 103,806 | — | $0 | 103,806 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2025-06-03 | 2025-06-03 | 89,312 | — | $0 | 89,312 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2025-05-13 | 2025-05-13 | 36,810 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2025-05-13 | 2025-05-13 | 36,810 | — | $0 | 85,174 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2024-05-13 | 2024-05-13 | 36,810 | — | $0 | 36,810 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2024-05-13 | 2024-05-13 | 44,906 | — | $0 | 44,906 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2024-04-28 | 2024-04-29 | 8,032 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2024-04-28 | 2024-04-29 | 8,032 | — | $0 | 48,364 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer deriv | 2023-06-16 | 2023-06-16 | 20,500 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer deriv | 2023-06-16 | 2023-06-16 | 30,000 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer | 2023-06-16 | 2023-06-16 | 2,071 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2023-05-21 | 2023-05-22 | 9,302 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2023-05-21 | 2023-05-22 | 9,302 | — | $0 | 40,332 | SEC↗ |
| RXDX Prometheus Biosciences, In | A Award | 2023-05-19 | 2023-05-19 | 2,071 | — | $0 | 2,071 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2023-04-28 | 2023-04-28 | 12,658 | — | $0 | 12,658 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2023-04-28 | 2023-04-28 | 8,032 | — | $0 | 8,032 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2022-05-21 | 2022-05-23 | 9,302 | — | $0 | 9,302 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2022-05-21 | 2022-05-23 | 14,402 | — | $0 | 14,402 | SEC↗ |
| RXDX Prometheus Biosciences, In | A Award deriv | 2022-05-19 | 2022-05-20 | 20,500 | — | $0 | 20,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2022-04-30 | 2022-05-02 | 4,024 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2022-04-30 | 2022-05-02 | 4,024 | — | $0 | 31,030 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2021-04-30 | 2021-05-03 | 6,475 | — | $0 | 6,475 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2021-04-30 | 2021-05-03 | 4,024 | — | $0 | 4,024 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-04-24 | 2021-04-27 | 10,638 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-04-24 | 2021-04-27 | 10,638 | — | $0 | 27,006 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-04-26 | 2020-04-27 | 3,466 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-04-26 | 2020-04-27 | 3,466 | — | $0 | 16,368 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2020-04-24 | 2020-04-27 | 10,638 | — | $0 | 10,638 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2020-04-24 | 2020-04-27 | 18,115 | — | $0 | 18,115 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2019-04-26 | 2019-04-29 | 3,466 | — | $0 | 3,466 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2019-04-26 | 2019-04-29 | 6,519 | — | $0 | 6,519 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2018-04-27 | 2018-04-27 | 2,857 | — | $0 | 2,857 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2018-04-27 | 2018-04-27 | 2,564 | — | $0 | 12,902 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2017-04-28 | 2017-05-01 | 2,857 | — | $0 | 2,857 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2017-04-28 | 2017-05-01 | 1,281 | — | $0 | 10,338 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2016-04-29 | 2016-05-02 | 2,857 | — | $0 | 2,857 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2016-04-29 | 2016-05-02 | 1,432 | — | $0 | 9,057 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2015-04-24 | 2015-04-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2015-04-24 | 2015-04-24 | 18,691 | — | $0 | 53,376 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2014-04-25 | 2014-04-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2014-04-25 | 2014-04-29 | 12,820 | — | $0 | 34,685 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2013-05-10 | 2013-05-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2013-05-10 | 2013-05-13 | 10,101 | — | $0 | 21,865 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2012-04-27 | 2012-04-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2012-04-27 | 2012-04-27 | 11,764 | — | $0 | 11,764 | SEC↗ |